Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Arcus Biosciences, Inc. | 400,000 | reported | 25 Mar 2019 | tx 1+400,000 |
| ALX ONCOLOGY HOLDINGS INC | 40,400 | reported | 20 Jan 2026 | tx 8+178,208 |
| MAXCYTE, INC. | 39,893 | reported | 25 Jun 2025 | tx 9+268,968−10,684 |
| Avalanche Biotechnologies, Inc. | 30,000 | reported | 23 Jun 2020 | tx 4+145,000 |
| LB PHARMACEUTICALS INC | 22,449 | reported | 10 Sept 2025 | tx 1+22,449 |
| BioAge Labs, Inc. | 22,000 | reported | 05 Jun 2025 | tx 4+68,497 |
| Versartis, Inc. | 14,250 | reported | 08 Apr 2020 | tx 3+200,000−42,750 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jan 2026 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 40,400 | 0.00 USD | deriv |
| 10 Sept 2025 | GRANT_AWARD | LB PHARMACEUTICALS INC | 22,449 | 0.00 USD | deriv |
| 25 Jun 2025 | SALE | MAXCYTE, INC. | 10,684 | 2.09 USD | |
| 18 Jun 2025 | GRANT_AWARD | MAXCYTE, INC. | 29,210 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | MAXCYTE, INC. | 50,790 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | BioAge Labs, Inc. | 22,000 | 0.00 USD | deriv |
| 21 Jan 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 40,400 | 0.00 USD | deriv |
| 02 Dec 2024 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 30,000 | 1.55 USD | |
| 25 Sept 2024 | GRANT_AWARD | BioAge Labs, Inc. | 15,000 | 0.00 USD | deriv |
| 17 Apr 2024 | GRANT_AWARD | BioAge Labs, Inc. | 28,497 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 20,200 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | MAXCYTE, INC. | 21,367 | 0.00 USD | |
| 11 Jun 2024 | GRANT_AWARD | MAXCYTE, INC. | 40,701 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | MAXCYTE, INC. | 50,000 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 20,200 | 0.00 USD | deriv |
| 20 Mar 2023 | GRANT_AWARD | MAXCYTE, INC. | 40,000 | 0.00 USD | deriv |
| 29 Jun 2022 | GRANT_AWARD | MAXCYTE, INC. | 26,900 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 12,004 | 0.00 USD | deriv |
| 09 Aug 2021 | GRANT_AWARD | MAXCYTE, INC. | 10,000 | 0.00 USD | deriv |
| 11 Jun 2021 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 12,004 | 0.00 USD | deriv |
| 21 Jul 2020 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 3,000 | 19.00 USD | |
| 23 Jun 2020 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 30,000 | 0.00 USD | deriv |
| 08 Apr 2020 | OTHER | Versartis, Inc. | 42,750 | 0.00 USD | |
| 09 Jan 2020 | GRANT_AWARD | Versartis, Inc. | 57,000 | 0.00 USD | |
| 09 Jan 2020 | GRANT_AWARD | Versartis, Inc. | 143,000 | 0.00 USD | deriv |